Efficacy of Brodalumab Vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post Hoc Analysis of Two Phase 3 Psoriasis Studies. J of Skin 2021, 5 (6), s51. https://doi.org/10.25251/skin.5.supp.51.